Re:The EpiPen, a Case Study in Health System Dysfunction
by cheriot on Saturday August 27, 2016 @03:12PM
(#12373703)
Did you see my original comment?
The point is to get the innovator payed in a way that justifies their investment AND help everyone that can be helped. I'm not bemoaning or blaming; the point is to design a better system. Right now paying the innovator requires limiting availability for no good reason.
Re:The EpiPen, a Case Study in Health System Dysfunction
by ende on Sunday August 28, 2016 @10:37PM
(#12379628)
I once saw someone propose an 'X-prize' style system of publicly funded incentive based competitions for medical device and pharma research. Interesting idea.
The point is to get the innovator payed in a way that justifies their investment AND help everyone that can be helped. I'm not bemoaning or blaming; the point is to design a better system. Right now paying the innovator requires limiting availability for no good reason.